lesinurad brand name zurampic urate transporter inhibitor treating high blood uric acid levels associated recommended together either allopurinol febuxostat medications received fda approval december european commission granted marketing authorisation valid throughout european union february february discontinued united states manufacturer business reasons subsequently withdrawn europe july lesinurad used combination xanthine oxidase inhibitor allopurinol febuxostat treating hyperuricemia high levels uric acid blood serum associated gout approved patients achieved target uric acid levels xanthine oxidase inhibitor drug contraindicated people tumour lysis syndrome syndrome juvenile gout well severe impairment kidney function including kidney transplant hemodialysis clinical trials serum creatinine important marker kidney function elevated patients depending dose compared placebo manifest kidney problems less frequent standard dose placebo kidney failure occurred placebo patients patients therapeutic standard dose patients double dose kidney stones frequencies common side effects influenza vs placebo headache vs gastroesophageal reflux disease vs hypersensitivity reactions rare substance mild inducer liver enzyme drugs metabolized enzyme shown slightly less effective combined lesinurad examples including simvastatin warfarin might also mild inducer hand lesinurad concentrations blood decreased drugs induce increased substances inhibit enzyme fluconazole well people genetically determined low activity may true microsomal epoxide hydrolase inhibitors valproic high dose aspirin related drugs reduce effectiveness antigout medications known conclusively whether also applies lesinurad low dose aspirin negatively affect lesinurad inhibits protein responsible reabsorption uric acid kidneys leads increased uric acid excretion urine consequently lower blood levels also inhibits protein associated hyperuricemia caused diuretic lesinurad quickly practically completely absorbed gut highest blood plasma concentrations reached one four hours bloodstream substance almost completely bound plasma proteins mainly metabolized mainly liver enzyme various oxidation products predominantly hydroxylated substance called epoxide latter quickly hydrolyzed diol microsomal epoxide hydrolase meh enzymes play minor roles metabolization glucuronidation enzymes also lesinurad excreted via urine feces biological halflife five hours excreted dose unchanged lesinurad rest people poor metabolizers exposed lesinurad concentrations higher normal function lesinurad white offwhite powder hygroscopic racemic mixture httpsenwikipediaorgwikilesinurad